GAM
NYMX

Geier Asset Management’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Geier Asset Management’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$55K Hold
35,000
– – 0.04% 83
2021
Q1 		$72K Hold
35,000
– – 0.05% 84
2020
Q4 		$91K Buy
+35,000
New +$77.3K 0.07% 79

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Geier Asset Management's NYMX Position: Q2 2021 in Review

Geier Asset Management held its Nymox Pharmaceutical Corp (NYMX) position steady in Q2 2021 at 35,000 shares worth $55K. The position accounts for 0.04% of the portfolio, ranked #83.

Geier Asset Management first reported a position in NYMX in Q4 2020 and has held it in 3 quarters since. The position peaked at $91K in Q4 2020. 51 funds tracked by Wall St. Rank hold NYMX as of Q2 2021.

  • Geier Asset Management held 35,000 shares of Nymox Pharmaceutical Corp worth $55K as of Q2 2021.
  • Geier Asset Management left its Nymox Pharmaceutical Corp share count unchanged in Q2 2021.
  • Nymox Pharmaceutical Corp made up 0.04% of Geier Asset Management's portfolio in Q2 2021, its #83 holding.
  • Geier Asset Management first reported a position in Nymox Pharmaceutical Corp in Q4 2020 and has held it in 3 quarters since.
  • Geier Asset Management's Nymox Pharmaceutical Corp position peaked at $91K in Q4 2020.
  • 51 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2021.

Based on Geier Asset Management's 13F filing for Q2 2021, filed 12 Jul 2021.